Evidence map›Paper›PMID 29592804›Full record

ArticleMicrobial cell factories2018

Metabolic engineering of a xylose pathway for biotechnological production of glycolate in Escherichia coli.

Min Liu, Yamei Ding, Mo Xian, Guang Zhao

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Metabolic engineering ofBiodesign research · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Biotransformation of ethylene glycol by engineeredSynthetic and systems biotechnology · 2024
    Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Min LiuCAS Key Laboratory of Biobased Materials, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Siences, Qingdao, 266101, China.
Yamei DingInstitute of Oceanology, Chinese Academy of Sciences, Qingdao, 266071, China.
Mo XianCAS Key Laboratory of Biobased Materials, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Siences, Qingdao, 266101, China. xianmo1@qibebt.ac.cn.
Guang ZhaoCAS Key Laboratory of Biobased Materials, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Siences, Qingdao, 266101, China. zhaoguang@qibebt.ac.cn.
Qingdao Institute of Bioenergy and Bioprocess Technology · CNInstitute of Oceanology · CNState Key Laboratory of Synthetic Chemistry · CN

Funding

Project funded by China Postdoctoral Science Foundation 2016M600564the National Natural Science Foundation of China 31670089the National Natural Science Foundation of China 31722001
6 · The paper itself

Abstract

backgroundGlycolate is a valuable chemical with extensive applications in many different fields. The traditional methods to synthesize glycolate are quite expensive and toxic. So, the biotechnological production of glycolate from sustainable feedstocks is of interest for its potential economic and environmental advantages. D-Xylose is the second most abundant sugar in nature and accounts for 18-30% of sugar in lignocellulose. New routes for the conversion of xylose to glycolate were explored.

resultsOverexpression of aceA and ghrA and deletion of aceB in Escherichia coli were examined for glycolate production from xylose, but the conversion was initially ineffective. Then, a new route for glycolate production was established in E. coli by introducing NAD

conclusionsA new route for glycolate production from xylose was established, and an engineered strain Q2742 was constructed from this new explored pathway. The engineering strain showed the highest reported productivity of glycolate to date. This research opened up a new prospect for bio-refinery of xylose and an alternative choice for industrial production of glycolate.

Indexed as

BiotechnologyEscherichia coliGlycolatesMetabolic EngineeringXyloseGlycolatesXyloseEscherichia coliGlycolaldehydeGlycolateGlyoxylateXylose

Identifiers

PMID29592804
PMCPMC5874992
OpenAlexW2804049143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.